AAB-001 (Bapineuzumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AAB-001 (Bapineuzumab), covering 2013-11-25 to 2013-11-25. Get the full timeline:
Most recent: Clinical Trial Update: AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]